During the past decade, Baskent University Ankara Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baskent University Ankara Hospital" #1 sponsor was "Baskent University" with 6 trials, followed by "Bayer" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Baskent University Ankara Hospital" with 2 trials sponsored and "Diskapi Teaching and Research Hospital" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baskent University Ankara Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Genmab" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Baskent University Ankara Hospital" are "Anemia" (2 trials), "Blood Transfusion" (2 trials), "Chronic Kidney Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Aortic Aneurysm, Thoracic" (1 trials). Many other conditions were trialed in "Baskent University Ankara Hospital" in a lesser frequency.

Most popular intervention types in "Baskent University Ankara Hospital" are "Drug" (16 trials), "Device" (5 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blood transfusion" (2 trials), "Paclitaxel" (2 trials), "Pembrolizumab" (2 trials), "methoxy polyethylene glycol-epoetin beta" (2 trials) and "Anti-TNF Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baskent University Ankara Hospital" are 24 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Baskent University Ankara Hospital". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Baskent University Ankara Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Baskent University Ankara Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".